Biofeedback
Defines medical necessity criteria for coverage of biofeedback therapy across specified indications (urinary incontinence, dysfunctional voiding in children, fecal incontinence, chronic constipation with dyssynergic defecation, tension/migraine headaches, chronic pain, and muscle re-education/spasticity-related abnormalities), and states that biofeedback for other indications is insufficiently supported.
Removed CPT 90911 and replaced with CPT 90912 and 90913.
Reworded criteria for clarity over multiple review cycles (e.g., removing gender-specific verbiage, removing rigid session limits, consolidating criteria language).
Clarified constipation indication to specify dyssynergic defecation.
Administrative cross-reference added to refer behavioral health biofeedback to CP.BH.300.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.